Department of Pediatrics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Shenyang, 110004, China.
Mol Med. 2024 Sep 28;30(1):164. doi: 10.1186/s10020-024-00872-1.
Asthma is a common immune disease with high morbidity in children. Type 2 inflammation is the center of asthma development, and mainly mediated by a subset of CD4 + T cells, T helper 2 (Th2) cells. Excess Th2 differentiation was generally associated with asthmatic attack. Casitas B-lineage lymphoma (c-CBL) was reported to involved in T cell development and databank showed its decreased expression in CD4 + T cells from peripheral blood of asthmatic children. This study aims to investigate the role of c-CBL in childhood asthma and Th2 differentiation, and explore the underlying mechanism.
We collected peripheral blood samples from clinical childhood asthma cases and healthy controls, and determined c-CBL expression in CD4 + T cells. Asthma was induced in neonatal mice by ovalbumin (OVA) intraperitoneal injection and aerosol inhalation, and c-CBL expression in CD4 + T cells from peripheral blood and spleen was measured. Gain-of-function experiments was performed to confirm the effects of c-CBL on Th2 differentiation in vitro. Finally, c-CBL was delivered into asthmatic mice via lentivirus infection to verify its effects on experimental asthma.
c-CBL was lowly expressed in CD4 + T cells from asthmatic children than those of healthy controls. Similarly, it was downregulated in CD4 + T cells from peripheral blood and spleen of asthma mice. Overexpression of c-CBL restrained lung pathological injury and type 2 inflammation in experimental asthmatic mice. Gain-of-function experiments demonstrated that c-CBL inhibited Th2 differentiation of CD4 + T cells from healthy children, and mediated the ubiquitination of lymphocyte cell-specific protein-tyrosine kinase (LCK). LCK acted as a kinase to phosphorylate and activate c-JUN, which was predicted to bind promoter sequence of CD28 by bioinformatic analysis. Dual-luciferase reporter assay verified that c-JUN and ETS1 synergically enhanced transcription of CD28, and this transcription activation was aggravated by LCK overexpression.
c-CBL alleviated asthma and suppressed Th2 differentiation by facilitating LCK ubiquitination, interrupting c-JUN activation and CD28 expression in vivo and in vitro. c-CBL/LCK/c-JUN/ETS1/CD28 axis was partially involved in childhood asthma, and may provide novel insights for clinical treatment for asthma.
哮喘是一种常见的儿童免疫性疾病,发病率高。2 型炎症是哮喘发展的中心,主要由一组 CD4+T 细胞,辅助性 T 细胞 2(Th2)细胞介导。Th2 分化过度通常与哮喘发作有关。已报道 Casitas B 细胞淋巴瘤(c-CBL)参与 T 细胞发育,数据库显示其在哮喘儿童外周血 CD4+T 细胞中的表达降低。本研究旨在探讨 c-CBL 在儿童哮喘和 Th2 分化中的作用,并探讨其潜在机制。
我们收集了临床儿童哮喘病例和健康对照者的外周血样本,并测定了 CD4+T 细胞中的 c-CBL 表达。通过卵清蛋白(OVA)腹腔注射和雾化吸入诱导新生小鼠哮喘,并测定外周血和脾 CD4+T 细胞中的 c-CBL 表达。进行功能获得实验以确认 c-CBL 对体外 Th2 分化的影响。最后,通过慢病毒感染将 c-CBL 递送至哮喘小鼠体内,以验证其对实验性哮喘的影响。
哮喘患儿 CD4+T 细胞中的 c-CBL 表达低于健康对照组。同样,哮喘小鼠外周血和脾 CD4+T 细胞中的 c-CBL 表达也下调。过表达 c-CBL 可抑制实验性哮喘小鼠的肺病理损伤和 2 型炎症。功能获得实验表明,c-CBL 抑制了健康儿童 CD4+T 细胞的 Th2 分化,并介导了淋巴细胞特异性蛋白酪氨酸激酶(LCK)的泛素化。LCK 作为一种激酶磷酸化并激活 c-JUN,生物信息学分析预测 c-JUN 与 CD28 启动子序列结合。双荧光素酶报告基因检测证实 c-JUN 和 ETS1 协同增强 CD28 的转录,而过表达 LCK 则加剧了这种转录激活。
c-CBL 通过促进 LCK 泛素化、阻断体内和体外 c-JUN 的激活和 CD28 的表达,减轻哮喘并抑制 Th2 分化。c-CBL/LCK/c-JUN/ETS1/CD28 轴部分参与了儿童哮喘,可为哮喘的临床治疗提供新的思路。